not tagged
not tagged
['cardio']
3 year results of evolut low-risk trial shows durable efficacy and safety of tavr compared with savr in low risk pts #acc23 #wccardio #accesspoints 
Non-Profit Founder/Leader | ❤️ Doc | Artist | Scientist | Educator | News Anchor https://t.co/7OIKCgMVAT | RT ≠ endorse | Disclaimer: https://t.co/bwmE2O3U5W